Fatty liver disease

One of the hardest parts of living with metabolic dysfunction-associated steatohepatitis (MASH) is carrying regrets about the past. The first time your doctor noticed…

The American Liver Foundation (ALF) is launching a first-of-its kind national database, called the ALF Living Donor Network, to connect people willing to…

A combination of pemafibrate and telmisartan, two medications approved in some countries to help manage cardiovascular conditions, may help reduce the buildup of liver fat…

October is National Liver Awareness Month and Liver Cancer Awareness Month, and advocacy organizations across the U.S., including the American Liver Foundation (ALF), are…

This morning I woke up to a changed forest outside my window. I live in a beautiful park in Baltimore, and I bought my house…

High blood pressure is a leading cardiometabolic risk factor — a condition linked to problems such as heart disease, stroke, and diabetes — associated with…

Since I learned I’d become a full-fledged metabolic dysfunction-associated steatohepatitis (MASH) patient, I’ve collected an assortment of friends with different medical issues. One of…

As part of a merger deal, Roche will acquire 89bio and its treatment candidate pegozafermin — an injection therapy now being tested in two global…

I enjoy listening to the sounds of the city outside my bedroom window at night. Cars hum down the thoroughfare where I live, their headlights…

The U.S. Food and Drug Administration (FDA) will evaluate the use of Fibroscan, a noninvasive test, to replace liver biopsies in clinical trials for metabolic…